Press Releases

July 8, 2021
Accolade Announces Results for Fiscal First Quarter 2022
Fiscal first quarter 2022 revenue of $59.5 million, a 66% increase compared to fiscal first quarter 2021 revenue of $35.9 million Company raises guidance for fiscal year 2022 to $300 million - $305 million, a 78% increase at the midpoint compared to fiscal year 2021 revenue of $170.4 million,
Additional Formats
June 17, 2021
Accolade to Announce Fiscal First Quarter 2022 Financial Results
SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal first quarter 2022 financial results on Thursday, July 8, 2021, after the market closes.
Additional Formats
June 9, 2021
Accolade Completes Acquisition of PlushCare
Accolade to begin offering virtual primary care and mental health consultations directly to members. $200bn+ combined total addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs.
Additional Formats
June 3, 2021
Betsy Nabel and Jeff Brodsky join Accolade Board of Directors
New board directors bring expertise in healthcare services, policy, and human resources SEATTLE , June 3, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company reinventing healthcare, today announced a series of changes to its board of directors that will bolster the board with significant
Additional Formats
June 1, 2021
Accolade to Participate in Upcoming Investor Conferences
SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: The 41st Annual William Blair Growth Stock Conference, including a fireside
Additional Formats
May 10, 2021
Accolade to Participate in Upcoming Investor Conferences
SEATTLE, May 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: The Bank of America 2021 Health Care Conference, including a presentation on
Additional Formats
April 23, 2021
Accolade to Acquire PlushCare
Accolade to begin offering virtual primary care and mental health consultations directly to members as a result of the acquisition. $200bn+ combined target addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs.
Additional Formats
March 25, 2021
Accolade Announces Pricing of $250 Million Convertible Senior Notes Offering
SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026 (the “Notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule
Additional Formats
Displaying 1 - 10 of 19

Search Investor Relations